Abstract
The use of oseltamivir at mass gatherings (MGs) or other crowded settings has not previously been systematically examined to synthesise the evidence of its usefulness. Here we have evaluated its effectiveness by reviewing the published literature. The effectiveness of oseltamivir at MGs is controversial because published clinical trials evaluating this are lacking. Its use, to date, has been predominantly therapeutic, i.e. to treat patients with confirmed or suspected influenza. There are some examples of its use in mass prophylaxis at MGs and other crowded settings like schools and camps, and closed settings such as prisons and aged care facilities. Most of the available studies indicate that oseltamivir use, whether therapeutic or prophylactic, is effective in containing influenza outbreaks in those settings though there are some reports of moderately high side effects, particularly among young children. Targeted prophylaxis of oseltamivir seems to help contain an outbreak of influenza at MG. A combination of ‘treatment of cases’ and ‘ring prophylaxis of contacts’ appears to be a feasible and economically sustainable strategy. Further research needs to be directed to uncertainties (e.g. how, when and for whom oseltamivir should be used) over oseltamivir’s place in influenza control at mass gatherings.
Keywords: Hajj, influenza, mass gatherings, oseltamivir, ring prophylaxis.
Infectious Disorders - Drug Targets
Title:Oseltamivir for Control of Influenza at Mass Gatherings
Volume: 13 Issue: 1
Author(s): Mohamed Tashani, Harunor Rashid, Iman Ridda, Leon Heron, Ziad A. Memish, Elizabeth Haworth and Robert Booy
Affiliation:
Keywords: Hajj, influenza, mass gatherings, oseltamivir, ring prophylaxis.
Abstract: The use of oseltamivir at mass gatherings (MGs) or other crowded settings has not previously been systematically examined to synthesise the evidence of its usefulness. Here we have evaluated its effectiveness by reviewing the published literature. The effectiveness of oseltamivir at MGs is controversial because published clinical trials evaluating this are lacking. Its use, to date, has been predominantly therapeutic, i.e. to treat patients with confirmed or suspected influenza. There are some examples of its use in mass prophylaxis at MGs and other crowded settings like schools and camps, and closed settings such as prisons and aged care facilities. Most of the available studies indicate that oseltamivir use, whether therapeutic or prophylactic, is effective in containing influenza outbreaks in those settings though there are some reports of moderately high side effects, particularly among young children. Targeted prophylaxis of oseltamivir seems to help contain an outbreak of influenza at MG. A combination of ‘treatment of cases’ and ‘ring prophylaxis of contacts’ appears to be a feasible and economically sustainable strategy. Further research needs to be directed to uncertainties (e.g. how, when and for whom oseltamivir should be used) over oseltamivir’s place in influenza control at mass gatherings.
Export Options
About this article
Cite this article as:
Tashani Mohamed, Rashid Harunor, Ridda Iman, Heron Leon, Memish A. Ziad, Haworth Elizabeth and Booy Robert, Oseltamivir for Control of Influenza at Mass Gatherings, Infectious Disorders - Drug Targets 2013; 13 (1) . https://dx.doi.org/ 10.2174/18715265112129990007
DOI https://dx.doi.org/ 10.2174/18715265112129990007 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Exploring Old Drugs for the Treatment of Hematological Malignancies
Current Medicinal Chemistry Renin Inhibition as a New Strategy to Combat Cardiovascular Disease
Current Hypertension Reviews Silicon Switches of Marketed Drugs
Mini-Reviews in Medicinal Chemistry Selective VEGFR Inhibitors for Anticancer Therapeutics in Clinical Use and Clinical Trials
Current Pharmaceutical Design New Therapeutic Strategies for Castration-Resistant Prostate Cancer
Recent Patents on Anti-Cancer Drug Discovery A Clinician’s Guide to Monoamine Oxidase Inhibitors
Current Psychiatry Reviews “Epileptic Encephalopathy” of Infancy and Childhood: Electro-Clinical Pictures and Recent Understandings
Current Neuropharmacology Pharmacogenetic Aspects of Therapy with Cholinesterase Inhibitors: The Role of CYP2D6 in Alzheimers Disease Pharmacogenetics
Current Alzheimer Research Pregabalin Dependence: A Case Report
Current Drug Safety Pharmacological Treatments for Obesity-Related Hypertension
Current Hypertension Reviews Neuroprotective Methodologies of Co-Enzyme Q10 Mediated Brain Hemorrhagic Treatment: Clinical and Pre-Clinical Findings
CNS & Neurological Disorders - Drug Targets Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview
Current Pharmaceutical Design Prevention of Intracerebral Haemorrhage
Current Drug Targets Emerging Targets in Neurodegeneration: New Opportunities for Alzheimer's Disease Treatment?
Current Topics in Medicinal Chemistry Therapeutic Strategies for Treatment of Inflammation-related Depression
Current Neuropharmacology Withdrawal Notice: Evaluation of Clinical Profile, Diagnostic Tests, And Prognosis of Crypto-coccal Meningitis in HIV Infected Patients in Western India
Infectious Disorders - Drug Targets New Patents on Topical Anesthetics
Recent Patents on Inflammation & Allergy Drug Discovery Kawasakis Disease, Acrodynia, and Mercury
Current Medicinal Chemistry An Insight into Molecular Mechanisms and Novel Therapeutic Approaches in Epileptogenesis
CNS & Neurological Disorders - Drug Targets Methemoglobinaemia in Diabetic Ketoacidosis Patient
New Emirates Medical Journal